MedPath

CANESTEN 3 DAY INTERNAL CREAM

CANESTEN 3 DAY INTERNAL CREAM

Approved
DIN Number

02150905

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

Bayer Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02150905
AIG Number0110231003
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
G01AF02 CLOTRIMAZOLE
Product Specifications
Dosage FormCream
Route of AdministrationVaginal
AHFS Classification84:04.08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

CLOTRIMAZOLEActive
Strength: 2 % / W/W
Monograph: CLOTRIMAZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.